Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 178

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Production of biopharmaceuticals and vaccines in plants via the chloroplast genome

Open access
Daniell, Henry·2006·Biotechnology Journal

Abstract

Transgenic plants offer many advantages, including low cost of production (by elimination of fermenters), storage and transportation; heat stability; and absence of human pathogens. When therapeutic proteins are orally delivered, plant cells protect antigens in the stomach through bioencapsulation and eliminate the need for expensive purification and sterile injections, in addition to development of both systemic and mucosal immunity. Chloroplast genetic engineering offers several advantages, including high levels of transgene expression, transgene containment via maternal inheritance and multi‐gene expression in a single transformation event. Hyper‐expression of vaccine antigens against cholera, tetanus, anthrax, plague or canine parvovirus (4–31% of total soluble protein, tsp) in transgenic chloroplasts (leaves) or non‐green plastids (carrots, tomato), as well as the availability of antibiotic‐free selectable markers or the ability to excise selectable marker genes, facilitate oral delivery. Hyper‐expression of several therapeutic proteins, including human serum albumin (11.1% tsp), somatotropin (7% tsp), interferon‐gamma (6% tsp), anti‐microbial peptide (21.5% tsp), facilitates efficient and economic purification. Also, the presence of chaperones and enzymes in chloroplasts facilitate assembly of complex multi‐subunit proteins and correct folding of human blood proteins with proper disulfide bonds. Functionality of chloroplast‐derived vaccine antigens and therapeutic proteins has been demonstrated by several assays, including the macrophage lysis assay, GM1‐ganglioside binding assay, protection of HeLa cells or human lung carcinoma cells against encephalomyocarditis virus, systemic immune response, protection against pathogen challenge, and growth or inhibition of cell cultures. Thus, transgenic chloroplasts are ideal bioreactors for production of functional human and animal therapeutic proteins in an environmentally friendly manner.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/biot.200600145

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 178

Metadata

Authors
Daniell, H.
Venue
Biotechnology Journal
Publisher
Wiley
Published
2006-10
Volume
1
Issue
10
Pages
1071-1079
ISSN
  • 1860-6768 (ISSN-L)
  • 1860-7314
OpenAlex
W1986838700
Cited by
178
References
1
FWCI
15.60
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Production of biopharmaceuticals and vaccines in plants via the chloroplast genome. https://app.cochat.ai/papers/10.1002/biot.200600145
The paper
Daniell, H. (2006). Production of biopharmaceuticals and vaccines in plants via the chloroplast genome. Biotechnology Journal. https://doi.org/10.1002/biot.200600145

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.